首页> 外文期刊>International Journal of Pharmaceutics >Hot melt extruded transdermal films based on amorphous solid dispersions in Eudragit RS PO: The inclusion of hydrophilic additives to develop moisture-activated release systems
【24h】

Hot melt extruded transdermal films based on amorphous solid dispersions in Eudragit RS PO: The inclusion of hydrophilic additives to develop moisture-activated release systems

机译:基于Eudragit RS PO中无定形固体分散体的热熔挤出透皮薄膜:包含亲水性添加剂以开发水分活化释放系统

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

A series of Eudragit RS PO-based hot melt extruded films were evaluated as potential transdermal systems, with particular emphasis on the inclusion of hydrophilic excipients to allow water sorption, which in turn would allow drug release on application to the skin. More specifically, sucrose, methyl cellulose, xanthan gum (Xantural175), poloxamer (Pluronic (R) F127), Gelucire 44/14 were added to Eudragit RS PO and assessed in terms of physical structure (modulated temperature DSC (MTDSC), thermogravimetric analysis (TGA), powder XRD (PXRD), scanning electron microscopy(SEM)) and in vitro drug release and permeation properties. In addition, the effect of prior hydration on drug permeation was studied for selected systems. Phase separation was noted for sucrose, methylcellulose (high loading), xanthan gum (high loading), poloxamer and Gelucire 44/14 (high loading) using both visual observation and MTDSC. PXRD studies indicated drug crystallization within the phase separated systems. SEM studies broadly followed the same pattern. Dissolution studies indicated that the hydrophilic excipients considerably enhanced the release rate, while Franz diffusion cell studies showed a much greater variability in effectiveness, which we ascribe to the paucity of water of hydration present which would not allow swellable additives such as xanthan to release the drug. However, films containing Gelucire 44/14 emerged as the most satisfactory systems, despite the higher additive loaded systems showing drug phase separation. This may be related to emulsification rather than swelling on contact with water, as noted for the permeation studies involving pre-hydration. This strategy therefore presents a promising approach for triggered transdermal drug delivery, activated by hydration from the skin itself. (C) 2016 Elsevier B.V. All rights reserved.
机译:一系列基于Eudragit RS PO的热熔挤出薄膜被评估为潜在的透皮系统,尤其着重于包含亲水性赋形剂以允许水吸附,进而使药物在施用于皮肤上时得以释放。更具体地,将蔗糖,甲基纤维素,黄原胶(Xantural175),泊洛沙姆(Pluronic F127),Gelucire 44/14添加到Eudragit RS PO中,并根据物理结构(调制温度DSC(MTDSC),热重分析)进行评估。 (TGA),粉末XRD(PXRD),扫描电子显微镜(SEM))以及体外药物释放和渗透性能。另外,针对选定的系统研究了预先水合对药物渗透的影响。使用目测和MTDSC对蔗糖,甲基纤维素(高负荷),黄原胶(高负荷),泊洛沙姆和Gelucire 44/14(高负荷)进行了相分离。 PXRD研究表明在相分离系统中药物结晶。 SEM研究大致遵循相同的模式。溶出度研究表明,亲水性赋形剂大大提高了释放速率,而Franz扩散池研究表明,其有效性存在较大差异,这归因于目前缺乏的水合水,这不允许诸如黄原胶等可溶胀性添加剂释放药物。 。然而,尽管添加了较高添加剂的体系显示出药物相分离,但包含Gelucire 44/14的薄膜仍是最令人满意的体系。如涉及预水合的渗透研究所述,这可能与乳化有关,而不是与水接触后溶胀有关。因此,该策略为触发透皮药物递送提供了一种有前途的方法,该透皮药物递送通过皮肤自身的水合作用而活化。 (C)2016 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号